Organization Overview
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
adefovir dipivoxil (hepsera) (5 trials)
adenosine monophosphate (1 trial)
albumin (Human) (Plasbumin) (1 trial)
amlodipine (norvasc) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (6 trials)
atorvastatin (lipitor) (1 trial)
beclomethasone (vanceril) (1 trial)
budesonide (rhinocort) (5 trials)
butorphanol (stadol) (1 trial)
ceftazidime (fortaz) (1 trial)
cenegermin-bkbj (oxervate) (1 trial)
cisatracurium (nimbex) (2 trials)
clopidogrel (plavix) (1 trial)
cyclophosphamide (cytoxan) (24 trials)
cyclosporine (sandimmune) (4 trials)
dapagliflozin (farxiga) (3 trials)
enalapril (vasotec) (3 trials)
esketamine (spravato) (2 trials)
etanercept (enbrel) (3 trials)
etoposide (vepesid) (9 trials)
formoterol (foradil) (5 trials)
glyburide (micronase) (1 trial)
hydromorphone (diladid) (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
idarubicin (idamycin) (6 trials)
insulin aspart (novolog) (1 trial)
insulin lispro (humalog) (1 trial)
interferon alpha-2b (Intron-A) (3 trials)
iodixanol (visipaque) (1 trial)
mercaptopurine (purinethol) (3 trials)
metformin (glucophage) (1 trial)
methacholine (provocholine) (1 trial)
metoprolol (lopressor) (1 trial)
mycophenolate (myfortic) (6 trials)
octreotide (sandostatin) (1 trial)
oseltamivir (tamiflu) (1 trial)
prednisone (meticorten) (5 trials)
progesterone (progestasert) (1 trial)
propofol (diprivan) (3 trials)
recombinant human choriogonadotropin alfa (Ovidrel) (2 trials)
remifentanil (ultiva) (3 trials)
rivaroxaban (xarelto) (1 trial)
s-{(1r,2e,4e,6z,9z)-1-[(1s)-4-carboxy-1-hydroxybutyl]pentadeca-2,4,6,9-tetraen-1-yl}-l-cysteinylglycine (1 trial)
saxagliptin (onglyza) (1 trial)
sevoflurane (ultane) (2 trials)
sitagliptin (januvia) (1 trial)
sorafenib (nexavar) (3 trials)
spironolactone (aldactone) (1 trial)
sulfasalazine (azulfidine) (1 trial)
telbivudine (tyzeka) (3 trials)
telmisartan (micardis) (1 trial)
terbutaline bisdimethylcarbamate (1 trial)
thymalfasin (zadaxin) (2 trials)
ticagrelor (brilinta) (1 trial)
vecuronium (norcuron) (1 trial)
acetylcysteine (mucomyst) (1 trial)
alemtuzumab (campath) (1 trial)
allogeneic blood cells (2 trials)
allogeneic lymphocytes (2 trials)
autologous mesenchymal stem cells (13 trials)
azathioprine (imuran) (1 trial)
bevacizumab (avastin) (2 trials)
bleomycin (blenoxane) (1 trial)
busulfan (myleran) (12 trials)
capecitabine (xeloda) (6 trials)
carboplatin (paraplatin) (5 trials)
cd25 monoclonal antibody (1 trial)
cisplatin (platinol) (9 trials)
daclatasvir (daklinza) (1 trial)
dasatinib (sprycel) (2 trials)
decitabine (dacogen) (9 trials)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (5 trials)
eltrombopag (promacta) (1 trial)
epirubicin (ellence) (3 trials)
filgrastim (neupogen) (1 trial)
fludarabine (fludara) (5 trials)
fluorouracil (efudex) (2 trials)
irinotecan (Camptosar) (2 trials)
ledipasvir (Harvoni) (2 trials)
megakaryocytic progenitor cells (1 trial)
melphalan (alkeran) (3 trials)
mitomycin (mutamycin) (1 trial)
monosialoganglioside (1 trial)
ombitasvir (Viekira Pak) (1 trial)
oprelvekin (Neumega) (1 trial)
oxaliplatin (eloxatin) (3 trials)
paritaprevir (viekira pak) (1 trial)
rituximab (rituxan) (3 trials)
sargramostim (leukine) (5 trials)
sevelamer (renagel) (2 trials)
sirolimus (rapamune) (1 trial)
sofosbuvir (sovaldi) (2 trials)
tacrolimus (prograf) (3 trials)
thalidomide (Thalomid) (2 trials)
umbilical cord mesenchymal stem cells (2 trials)
ursodeoxycholic acid (1 trial)
ursodeoxycholyltaurine (1 trial)
allogeneic adipose derived mesenchymal stem cell (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
allogeneic stem cells (1 trial)
autologous cd34+ cells genetically modified (1 trial)
autologous endothelial progenitor cells (1 trial)
bronchial basal cells (1 trial)
cd44v6-specific car gene-engineered t cells (1 trial)
gemcitabine (gemzar) (3 trials)
itraconazole (sporanox) (1 trial)
lenalidomide (revlimid) (2 trials)
lenvatinib (lenvima) (1 trial)
masct:multiple antigens specific cellular therapy (1 trial)
methylprednisolone (medrol) (1 trial)
muc1/cll1/cd33/cd38/cd56/cd123-specific gene-engineered t cells (1 trial)
albuterol (proventil) (1 trial)
allogeneic cord blood (1 trial)
apalutamide (erleada) (1 trial)
autologous hematopoietic cell (1 trial)
autologous platelets (1 trial)
benazepril (lotensin) (3 trials)
bifidobacterium lactis (1 trial)
clarithromycin (biaxin) (1 trial)
dexmedetomidine (precedex) (1 trial)
furazolidone (furoxone) (1 trial)
haplo-identical hematopoietic stem cells (1 trial)
hemopoietic stem cell (3 trials)
human fecal microbiota (2 trials)
infliximab (remicade) (1 trial)
ipratropium (atrovent) (1 trial)
Lactobacillus acidophilus (1 trial)
lactobacillus gasseri (1 trial)
lactobacillus reuteri (1 trial)
levofloxacin (levaquin) (1 trial)
metronidazole (flagyl) (1 trial)
norepinephrine (levophed) (1 trial)
oxytocin (syntocinon) (1 trial)
Acute Disease (Phase 3)
Agnosia (Phase 4)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Ankylosis (Phase 3)
Asthma (Phase 4)
Atrial Fibrillation (Phase 4)
beta-Thalassemia (Phase 2)
Bone Diseases (Phase 3)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 2)
Bronchopulmonary Dysplasia (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenosquamous (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Cerebral Infarction (Phase 2)
Cerebral Small Vessel Diseases (Phase 4)
Cholestasis (Phase 3)
Chronic Disease (Phase 4)
Cognitive Dysfunction (Phase 4)
Coinfection (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 3)
Congenital Abnormalities (Phase 3)
Crohn Disease (Phase 3)
Cytomegalovirus Infections (Phase 2)
Death (Phase 1)
Delayed Emergence from Anesthesia (Phase 4)
Dementia (Phase 2)
Dementia, Vascular (Phase 2)
Depression (Phase 2)
Depressive Disorder (Phase 2)
Depressive Disorder, Major (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Foot (Phase 1)
Diabetic Nephropathies (Phase 4)
Dry Eye Syndromes (Phase 3)
Esophageal Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 3)
Fatty Liver (Phase 4)
Fibrosis (Phase 4)
Glaucoma (Phase 3)
Graft vs Host Disease (Phase 4)
Hematologic Diseases (Phase 3)
Hemorrhage (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 4)
Hyperbilirubinemia (Phase 4)
Hyperbilirubinemia, Neonatal (Phase 4)
Hyperhomocysteinemia (Phase 4)
Hyperphosphatemia (Phase 3)
Hypertension (Phase 4)
Hypertension, Portal (Phase 4)
Infarction (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Infections (Phase 3)
Infertility (Phase 4)
Influenza, Human (Phase 4)
Ischemia (Phase 1)
Keratoconjunctivitis Sicca (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 4)
Leukemia, B-Cell (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 4)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, T-Cell (Phase 3)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 4)
Liver Neoplasms (Phase 1)
Lung Diseases (Phase 4)
Lung Diseases, Interstitial (Phase 2)
Lung Diseases, Obstructive (Phase 4)
Lung Neoplasms (Phase 3)
Lupus Nephritis (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Peripheral (Phase 3)
Multiple Myeloma (Phase 3)
Musculoskeletal Diseases (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myocardial Stunning (Phase 4)
Nasopharyngeal Carcinoma (Phase 3)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Nephritis (Phase 3)
Nephrosis (Phase 3)
Nephrotic Syndrome (Phase 3)
Neuroblastoma (Phase 2)
Neuromyelitis Optica (Phase 4)
Neurotoxicity Syndromes (Phase 3)
Neutropenia (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 4)
Osteosarcoma (Phase 4)
Ovarian Neoplasms (Phase 3)
Peripheral Arterial Disease (Phase 1)
Peripheral Vascular Diseases (Phase 1)
Peritoneal Neoplasms (Phase 3)
Philadelphia Chromosome (Phase 3)
Polycystic Ovary Syndrome (Phase 3)
Postoperative Complications (Phase 4)
Preleukemia (Phase 1)
Premature Birth (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Recurrence (Phase 4)
Renal Insufficiency (Phase 2)
Renal Insufficiency, Chronic (Phase 4)
Retinitis (Phase 1)
Retinitis Pigmentosa (Phase 1)
Sepsis (Phase 2)
Shock, Septic (Phase 2)
Soft Tissue Neoplasms (Phase 1)
Spinal Diseases (Phase 3)
Spondylarthritis (Phase 4)
Spondylarthropathies (Phase 3)
Spondylitis (Phase 4)
Spondylitis, Ankylosing (Phase 4)
Stomach Neoplasms (Phase 3)
Stroke (Phase 4)
Syndrome (Phase 3)
Thalassemia (Phase 2)
Thrombocytopenia (Phase 3)
Thrombosis (Phase 3)
Toxemia (Phase 2)
Urinary Bladder Neoplasms (Phase 1)
Uterine Cervical Neoplasms (Phase 2)
Vascular Diseases (Phase 1)
Vascular Malformations (Phase 3)
Virus Diseases (Phase 2)